Skip to main content

Table 2 Overview of serum biochemical parameters in patients with therapy (G2) and without therapy (de novo, G1). Data are presented as mean ± SD

From: Association of LH/FSH ratio with menstrual cycle regularity and clinical features of patients with polycystic ovary syndrome

Parameters

Group

Mean

Range

Sig.

LH (IU/mL)

G1

13.57±6.54

3.30–43.00

0.125

G2

12.37±6.16

1.68–31.10

FSH (IU/mL)

G1

6.29±2.97

2.04–13.90

0.244

G2

5.99±2.30

1.20–10.69

LH/FSH

G1

2.56±1.71

0.62–9.75

0.043*

G2

2.41±1.72

0.27–8.09

Glucose (mmol/L)

G1

6.23±1.22

3.86–10.21

0.003*

G2

5.12±0.62

3.23–6.71

Insulin (ulU/mL)

G1

19.21±7.43

6.22–44.00

0.000**

G2

7.35±4.21

3.26–15.20

IR

G1

3.22±1.45

1.90–6.60

0.000**

G2

1.42±0.53

0.35–2.30

Cholesterol (mmol/L)

G1

5.97±1.13

3.00–7.68

0.002*

G2

4.92±1.82

2.64–6.62

Tryacilglycerol (mmol/L)

G1

1.57±0.92

0.43–3.95

0.471

G2

1.22±0.48

0.42–3.70

HDL (mmol/L)

G1

1.42±0.37

0.73–2.22

0.769

G2

1.39±0.43

0.59–2.20

LDL (mmol/L)

G1

3.56±0.45

1.27–4.90

0.001*

G2

2.56±0.63

1.05–4.20

  1. Sig. indicate differences between groups (G1 vs G2)
  2. *Statistically significant at 0.05 (P<0.05) and ** at 0.001 (P<0.001)